HOMOZYGOUS F508DEL MUTATION

Clinical trials for HOMOZYGOUS F508DEL MUTATION explained in plain language.

Never miss a new study

Get alerted when new HOMOZYGOUS F508DEL MUTATION trials appear

Sign up with your email to follow new studies for HOMOZYGOUS F508DEL MUTATION, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Completed 1

Lab test could predict which cystic fibrosis patients benefit from drug

Knowledge-focused Completed

This study aimed to see if a laboratory test on patients' own nasal cells could predict how well they would respond to the cystic fibrosis drug Orkambi. Researchers tested 91 patients with a specific genetic form of cystic fibrosis who were starting Orkambi treatment. They compar…

Matched conditions: HOMOZYGOUS F508DEL MUTATION

Phase: NA • Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Knowledge-focused

Last updated Apr 01, 2026 14:41 UTC

HOMOZYGOUS F508DEL MUTATION

Get alerted when new HOMOZYGOUS F508DEL MUTATION trials appear

Lab test could predict which cystic fibrosis patients benefit from drug